Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹917.10
71.15 (8.41%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹4.65K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
204.2
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹480+91.1%
52W High₹935-1.9%
Current Price
₹917.10
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹733.68
Upper Circuit₹1,100.52
Reference Price
₹917.10
Investment Checklist
Triple Bottom on 1W (BREAKOUT CONFIRMED) — target ₹934.4
Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹1026.38
Composite score 62.53 (STRONG_BUY) with 56.3% confidence
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
RSI at 82.4 — overbought, pullback risk
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
56%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
795.48
EMA50
713.27
EMA200
695.04
Price Action
UPTREND
BULLISH
Higher Highs7
Higher Lows7
Lower Highs2
Lower Lows2
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹899.00
₹875.70
₹816.25
₹801.94
₹768.75
Volume Analysis
TrendINCREASING
Change+65.70%
Unusual Volume
Yes (3.98x avg)
Stop Loss Levels
Fixed Risk
1% Risk₹907.93
3% Risk₹889.59
5% Risk₹871.25
7% Risk (Custom)
₹852.90Technical Levels
1x ATR (Volatility)₹876.08
2x ATR (Swing)₹835.06
3x ATR (Trend)₹794.04
Immediate Support₹899.00
Moving Averages
EMA 9 (Short-term)₹846.44
EMA 20 (Medium-term)₹795.48
EMA 50 (Trend)₹713.27
EMA 200 (Long-term)₹695.04
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹229.5 Cr | ₹172.9 Cr | ₹193.5 Cr | ₹207.3 Cr |
| Net Profit | ₹22.3 Cr | ₹14.9 Cr | ₹-5.7 Cr | ₹-12.6 Cr |
| EPS | — | ₹2.94 | ₹-1.13 | ₹-2.49 |
| Operating Profit | ₹31.9 Cr | ₹25.6 Cr | ₹9.3 Cr | ₹6,07,000 |
ROE
7.86%
ROCE
7.64%
Debt/Equity
0.14
Current Ratio
2.83
OPM
0.03%
NPM
-6.09%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 02 Aug 2023 | Annual General Meeting | AGM |
| 22 Dec 2022 | Extra Ordinary General Meeting | OTHERS |
| 06 Jul 2022 | Annual General Meeting | AGM |
| 04 Aug 2021 | Annual General Meeting | AGM |
| 18 Jun 2021 | Extra Ordinary General Meeting | OTHERS |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ORCHPHARMA
View AllNEWS
positive
Business Standard - Markets 18d ago
Orchid Pharma rises after Q4 net profit increases 7% to Rs 24 crore
Orchid Pharma rose 1.10% to Rs 723.50 after the company reported a 6.68% increase in consolidated net profit to Rs 23.78 crore for the fourth quarter ended March 2026, compared with Rs 22.29 crore in the corresponding quarter last year.
ORCHPHARMAHealthcare